Cirrhosis is an advanced form of liver disease that has many causes, not just chronic hepatitis C infection. Alcoholism, autoimmune diseases, hepatitis B, and other conditions can result in cirrhosis. In the case of hepatitis C, the virus attacks the liver and may gradually lead to the formation of scar tissue. Early damage is called fibrosis; severe damage is cirrhosis. About 5 to 20 percent of people infected with HCV, will develop cirrhosis over a 20-to-30-year period of HCV infection.

Although cirrhosis is usually irreversible, reversal was observed in nearly half of all cirrhotic patients whose hepatitis C was cured. Otherwise, liver transplantation is the only treatment for cirrhosis.

Cirrhosis has two phases, compensated and decompensated. Compensated cirrhosis means that the liver is still functioning relatively well. At this stage, the early symptoms may still be vague and some people may be unaware that they have cirrhosis. The symptoms of compensated cirrhosis include:

  • Appetite loss
  • Confusion or difficulty thinking
  • Dark, cola-colored urine
  • Easy bruising and abnormal bleeding
  • Edema in the feet and legs (swelling from fluid build-up)
  • Fatigue (feeling tired)
  • Impotence, shrinking of the testicles, and breast swelling in men
  • Itchy skin (pruritus)
  • Jaundice (yellowing in the skin, mucous membranes, or eyes)
  • Muscle cramping
  • Nausea
  • Pale or clay-colored stools
  • Redness on the palms of the hands
  • Spider veins (small red spidery veins on the skin)
  • Weight loss

For information about hepatitis C treatment options for patients with compensated cirrhosis, visit: Hepatitis C Treatment-Naive Recommendations or Hepatitis C Re-Treatment Recommendations

Decompensated cirrhosis means that the liver is not functioning well. Some serious complications that occur with decompensated cirrhosis are:

  • Ascites, which is bloating from fluid build-up in the abdomen
  • Hepatic encephalopathy (HE) is a brain disorder that develops when the liver is unable to remove ammonia and other toxins from the body. HE may cause impaired concentration, sleep disturbances, confusion, or coma.
  • Spontaneous bacterial peritonitis (SBP) is associated with ascites, an infection of the membrane that covers the abdominal organs)
  • Variceal hemorrhage is severe bleeding from enlarged veins in the esophagus and upper stomach)

Patients with decompensated cirrhosis should be referred to a medical provider with expertise in treating this advanced liver disease, ideally in a liver transplant center. Here are recommended hepatitis C treatments for patients with decompensated cirrhosis:

AASLD HCV Treatment Recommendations for  Patients with Decompensated Cirrhosis
Recommended Alternative
Genotype 1 treatment-naive and -experienced Daklinza + Sovaldi + low initial dose ribavirin for 12 weeks
OR
Harvoni + low initial dose of ribavirin for 12 weeks
Patients who are unable to take ribavirin: Daklinza + Sovaldi for 24 weeks
Genotype 1 treatment-experienced who failed prior Sovaldi-based regimen Harvoni + low initial dose of ribavirin  for 24 weeks none
Genotype 2 treatment-naive and -experienced Daklinza + Sovaldi + low initial dose ribavirin for 12 weeks
OR
Sovaldi + ribavirin for up to 48 weeks
none
Genotype 3 treatment-naive and -experienced Daklinza + Sovaldi + low initial dose ribavirin for 12 weeks
OR
Sovaldi + ribavirin for up to 48 weeks
none
Genotype 4 treatment-naive and -experienced Daklinza + Sovaldi + low initial dose ribavirin for 12 weeks
OR
Harvoni + low initial dose of ribavirin for 12 weeks
Patients who are unable to take ribavirin: Daklinza + Sovaldi for 24 weeks
Genotype 4 treatment-experienced who failed prior Sovaldi-based regimen Harvoni + low initial dose of ribavirin  for 24 weeks none
Genotype 5 none none
Genotype 6 none none

Last Revised: October 26, 2015